David Jonathan Glass

Person

Cortlandt Manor, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
Rapamycin derivatives
- Patent number 12,091,424
- Issue date Sep 17, 2024
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating structural and/or functional cardiac abnormaliti...
- Patent number 11,834,508
- Issue date Dec 5, 2023
- Novartis AG
- Anthony Rosenzweig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 11,591,404
- Issue date Feb 28, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 11,578,130
- Issue date Feb 14, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-BCMA chimeric antigen receptor
- Patent number 11,084,880
- Issue date Aug 10, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for treating and/or reducing the likelihood of heart failur...
- Patent number 10,982,000
- Issue date Apr 20, 2021
- Novartis AG
- Anthony Rosenzweig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Rapamycin derivatives
- Patent number 10,800,793
- Issue date Oct 13, 2020
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biomarkers predictive of therapeutic responsiveness to chimeric ant...
- Patent number 10,774,388
- Issue date Sep 15, 2020
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 10,703,819
- Issue date Jul 7, 2020
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical combination of everolimus with dactolisib
- Patent number 10,576,076
- Issue date Mar 3, 2020
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CLL-1 chimeric antigen receptor
- Patent number 10,568,947
- Issue date Feb 25, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using anti-CD19 Chimeric Antigen Receptor
- Patent number 10,357,514
- Issue date Jul 23, 2019
- The Trustees of the University of Pennsylvania
- Carl H. June
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Low, immune enhancing, dose MTOR inhibitors and uses thereof
- Patent number 10,286,069
- Issue date May 14, 2019
- Novartis AG
- Joan Mannick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Regulatable chimeric antigen receptor
- Patent number 10,287,354
- Issue date May 14, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor
- Patent number 10,174,095
- Issue date Jan 8, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Production of therapeutic proteins in genetically modified mammalia...
- Patent number 10,030,063
- Issue date Jul 24, 2018
- Novartis AG
- Mara Fornaro
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Low, immune enhancing, dose mtor inhibitors and uses thereof
- Patent number 10,004,803
- Issue date Jun 26, 2018
- Novartis AG
- Joan Mannick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using a CD123 chimeric antigen receptor
- Patent number 9,815,901
- Issue date Nov 14, 2017
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions using a Klotho-FGF23 fusion polypeptide
- Patent number 9,475,857
- Issue date Oct 25, 2016
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions using Klotho-FGF fusion polypeptides
- Patent number 9,458,209
- Issue date Oct 4, 2016
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for treating metabolic disorders by administration of an ant...
- Patent number 9,365,651
- Issue date Jun 14, 2016
- Novartis AG
- Jerome Feige
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions using FGF23 variant polypeptides with redu...
- Patent number 9,139,631
- Issue date Sep 22, 2015
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions using Kloto-FGF23 fusion polypeptides
- Patent number 8,932,589
- Issue date Jan 13, 2015
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized insulin-like growth factor polypeptides
- Patent number 8,722,621
- Issue date May 13, 2014
- Novartis AG
- David Jonathan Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions using Klotho-FGF fusion polypeptides
- Patent number 8,481,031
- Issue date Jul 9, 2013
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-1 fusion polypeptides and therapeutic uses thereof
- Patent number 8,445,434
- Issue date May 21, 2013
- REGENERON PHARMACEUTICALS, INC.
- David J. Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions using FGF23 fusion polypeptides
- Patent number 8,420,088
- Issue date Apr 16, 2013
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Stabilized insulin-like growth factor polypeptides
- Patent number 8,343,918
- Issue date Jan 1, 2013
- Novartis AG
- David Jonathan Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IGF-1 fusion polypeptides and therapeutic uses thereof
- Patent number 8,158,581
- Issue date Apr 17, 2012
- REGENERON PHARMACEUTICALS, INC.
- David J. Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of increasing muscle mass with IGF-1 fusion polypeptides
- Patent number 7,837,999
- Issue date Nov 23, 2010
- REGENERON PHARMACEUTICALS, INC.
- David J. Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR PREVENTING AND TREATING HEART DISEASE
- Publication number 20240158514
- Publication date May 16, 2024
- Novartis AG
- Anthony ROSENZWEIG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230220090
- Publication date Jul 13, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential...
- Publication number 20230113866
- Publication date Apr 13, 2023
- Regeneron Pharmaceuticals, Inc.
- Eric Jorgenson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20230026049
- Publication date Jan 26, 2023
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RAPAMYCIN DERIVATIVES
- Publication number 20220242878
- Publication date Aug 4, 2022
- Novartis AG
- Simone BONAZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMY...
- Publication number 20220202787
- Publication date Jun 30, 2022
- Novartis AG
- Simone Bonazzi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAPAMYCIN DERIVATIVES
- Publication number 20220064185
- Publication date Mar 3, 2022
- Novartis AG
- Simone Bonazzi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...
- Publication number 20220064316
- Publication date Mar 3, 2022
- The Trustees of the University of Pennsylvania
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for Preventing and Treating Cardiac Dysfunction and COVID-1...
- Publication number 20220056119
- Publication date Feb 24, 2022
- Regeneron Pharmaceuticals, Inc.
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREVENTING AND TREATING HEART DISEASE
- Publication number 20210309749
- Publication date Oct 7, 2021
- Novartis AG
- Anthony ROSENZWEIG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...
- Publication number 20210172020
- Publication date Jun 10, 2021
- Novartis AG
- Felipe Bedoya
- G01 - MEASURING TESTING
Information Patent Application
PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB
- Publication number 20210030741
- Publication date Feb 4, 2021
- Novartis AG
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20210002377
- Publication date Jan 7, 2021
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NOVEL RAPAMYCIN DERIVATIVES
- Publication number 20200392159
- Publication date Dec 17, 2020
- Novartis AG
- Simone BONAZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY
- Publication number 20200339651
- Publication date Oct 29, 2020
- Novartis AG
- Jennifer Brogdon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20200215171
- Publication date Jul 9, 2020
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
- Publication number 20200054742
- Publication date Feb 20, 2020
- Novartis AG
- Joan MANNICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR PREVENTING AND TREATING HEART DISEASE
- Publication number 20200031940
- Publication date Jan 30, 2020
- Anthony ROSENZWEIG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190388471
- Publication date Dec 26, 2019
- Novartis AG
- Carl H. June
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REGULATABLE CHIMERIC ANTIGEN RECEPTOR
- Publication number 20190263914
- Publication date Aug 29, 2019
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...
- Publication number 20190153061
- Publication date May 23, 2019
- Novartis AG
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL RAPAMYCIN DERIVATIVES
- Publication number 20190092788
- Publication date Mar 28, 2019
- Novartis AG
- Simone BONAZZI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
- Publication number 20180369370
- Publication date Dec 27, 2018
- Novartis AG
- Joan MANNICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY
- Publication number 20180334490
- Publication date Nov 22, 2018
- Jennifer Brogdon
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20180312595
- Publication date Nov 1, 2018
- Novartis AG
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB
- Publication number 20180289694
- Publication date Oct 11, 2018
- David Glass
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...
- Publication number 20180118834
- Publication date May 3, 2018
- Jennifer Brogdon
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of treating Sporadic Inclusion Body Myositis
- Publication number 20180066061
- Publication date Mar 8, 2018
- Novartis AG
- Dimitris Papanicolaou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...
- Publication number 20170306416
- Publication date Oct 26, 2017
- Felipe Bedoya
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
- Publication number 20170281753
- Publication date Oct 5, 2017
- NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.
- Joan MANNICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David Jonathan Glass

Person

Patents Grantslast 30 patents

Rapamycin derivatives

Method of treating structural and/or functional cardiac abnormaliti...

Treatment of cancer using a CD123 chimeric antigen receptor

Regulatable chimeric antigen receptor

Anti-BCMA chimeric antigen receptor

Methods for treating and/or reducing the likelihood of heart failur...

Rapamycin derivatives

Biomarkers predictive of therapeutic responsiveness to chimeric ant...

Treatment of cancer using a CD123 chimeric antigen receptor

Pharmaceutical combination of everolimus with dactolisib

Treatment of cancer using a CLL-1 chimeric antigen receptor

Treatment of cancer using anti-CD19 Chimeric Antigen Receptor

Low, immune enhancing, dose MTOR inhibitors and uses thereof

Regulatable chimeric antigen receptor

Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor

Production of therapeutic proteins in genetically modified mammalia...

Low, immune enhancing, dose mtor inhibitors and uses thereof

Treatment of cancer using a CD123 chimeric antigen receptor

Methods and compositions using a Klotho-FGF23 fusion polypeptide

Methods and compositions using Klotho-FGF fusion polypeptides

Method for treating metabolic disorders by administration of an ant...

Methods and compositions using FGF23 variant polypeptides with redu...

Methods and compositions using Kloto-FGF23 fusion polypeptides

Stabilized insulin-like growth factor polypeptides

Methods and compositions using Klotho-FGF fusion polypeptides

IGF-1 fusion polypeptides and therapeutic uses thereof

Methods and compositions using FGF23 fusion polypeptides

Stabilized insulin-like growth factor polypeptides

IGF-1 fusion polypeptides and therapeutic uses thereof

Method of increasing muscle mass with IGF-1 fusion polypeptides

Patents Applicationslast 30 patents

METHODS FOR PREVENTING AND TREATING HEART DISEASE

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

Methods Of Treating Clonal Hematopoiesis Of Indeterminate Potential...

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

RAPAMYCIN DERIVATIVES

ISOTHIAZOLIDINE 1,1-DIOXIDE AND 1,4-BUTAN SULTONE CONTAINING RAPAMY...

RAPAMYCIN DERIVATIVES

TREATMENT OF CANCER USING HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RECE...

Methods for Preventing and Treating Cardiac Dysfunction and COVID-1...

METHODS FOR PREVENTING AND TREATING HEART DISEASE

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...

PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

NOVEL RAPAMYCIN DERIVATIVES

METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY

TREATMENT OF CANCER USING A CLL-1 CHIMERIC ANTIGEN RECEPTOR

LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF

METHODS FOR PREVENTING AND TREATING HEART DISEASE

TREATMENT OF CANCER USING ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

TREATMENT OF CANCER USING 5 HUMANIZED ANTI-BCMA CHIMERIC ANTIGEN RE...

NOVEL RAPAMYCIN DERIVATIVES

LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF

METHODS FOR B CELL PRECONDITIONING IN CAR THERAPY

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB

PHOSPHOGLYCERATE KINASE 1 (PGK) PROMOTERS AND METHODS OF USE FOR EX...

Methods of treating Sporadic Inclusion Body Myositis

BIOMARKERS PREDICTIVE OF THERAPEUTIC RESPONSIVENESS TO CHIMERIC ANT...

LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF